Copenhagen Denmark / York UK
Press Release : Market-leaders combine to form the Unilabs Drug Development Services Group
York Bioanalytical Solutions (YBS) and Capio Diagnostik Denmark join forces under the name Unilabs Drug Development Services to strengthen their position as market leader in bioanalytical support for drug development studies. The new structure and brand brings together established bioanalytical and logistics services and gives a solid platform to build on the recognised reputation for quality and delivery.
As a leading supplier of bioanalytical and logistics services to the global pharmaceutical and biotech industry, Unilabs Drug Development Services will offer a comprehensive list of analytical techniques including LC-MS/MS and immunoassay for both small and large molecule bioanalysis. Yvonne Lech, Managing Director of Unilabs Drug Development Service Group, stated: “The fact that we are now united under a single brand name and symbol will give us a distinctive competitive advantage. It strengthens our integration work, where our ambition is to provide an even better service offer to our customers, building on our total experience and competence.”
Unilabs’ personnel are selected on the basis of their professional attitude, experience and commitment to maintaining and enhancing the quality and range of services Unilabs provide: scientific competence enables Unilabs to quickly develop robust assays that run consistently and efficiently. An independent QA group ensures that exacting standards are maintained.
Jeremy Cook, Managing Director (York) of Unilabs Drug Development Services Group said:” The Unilabs commitment to customer satisfaction and service ensures the level of quality and growth required to meet the future needs of pharmaceutical and biotech clients.”
The new brand is designed to reflect today’s Unilabs – a customer-oriented company that will continue to be a strong force in bioanalytical support for the drug development industry.
For more information please visit www.unilabs.dk and www.yorkbio.com OR please contact: Unilabs Drug Development Service Group, UK
Jeremy Cook, Managing Director (York), Tel: +44(0)1904 686061, email: jeremy.cook@yorkbio.com
Unilabs Drug Development Service Group, Denmark Yvonne Lech, Managing Director, Tel: +45 23 44 12 84; email: yvonne.lech@unilabs.com
Unilabs is Europe’s leading diagnostic services company within laboratory and radiology services. We have more than 3000 employees and operate more than 80 laboratories and 30 radiology units in Denmark, Finland, France, Italy, Norway, Portugal, Russia, Spain, Sweden, Switzerland, and the United Kingdom. Our customers are both public and private healthcare units such as hospitals, outpatients clinics, GPs, occupational health units, insurance companies, drug development companies and CROs. We supply medical laboratory analyses and services within clinical biochemistry, clinical haematology, clinical microbiology, cellular pathology, transfusion medicine and clinical trials. Our radiology units supply services within conventional X-ray, mammography, MRI, CT, ultrasound, fluoroscopy, osteoporosis and nuclear medicine.